Online citations, reference lists, and bibliographies.

Time-dependent Release Of Growth Factors From Implant Surfaces Treated With Plasma Rich In Growth Factors.

María Belén Sánchez-Ilárduya, E. Trouche, R. Tejero, G. Orive, Ilya Reviakine, E. Anitua
Published 2013 · Materials Science, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Plasma rich in growth factors (PRGFs) technology is an autologous platelet-rich plasma approach that provides a pool of growth factors and cytokines that have been shown to increase tissue regeneration and accelerate dental implant osseointegration. In this framework, the spatiotemporal release of growth factors and the establishment of a provisional fibrin matrix are likely to be key aspects governing the stimulation of the early phases of tissue regeneration around implants. We investigated the kinetics of growth factor release at implant surfaces functionalized either with PRGFs or platelet-poor plasma and correlated the results obtained with the morphology of the resulting interfaces. Our main finding is that activation and clot formation favors longer residence times of the growth factors at the interfaces studied, probably due to their retention in the adsorbed fibrin matrix. The concentration of the platelet-derived growth factors above the interfaces becomes negligible after 2-4 days and is significantly higher in the case of activated interfaces than in the case of nonactivated ones, whereas that of the plasmatic hepatocyte growth factor is independent of platelet concentration and activation, and remains significant for up to 9 days. Platelet-rich plasma preparations should be activated to permit growth factor release and thereby facilitate implant surface osseointegration.
This paper references
10.1126/science.328.5978.562
Cell biology. Beyond clotting: the powers of platelets.
M. Leslie (2010)
10.1563/736.1
Enhancement of osseointegration by generating a dynamic implant surface.
E. Anitua (2006)
10.1007/978-3-540-78281-0_5
Angiogenesis inhibition in cancer therapy: platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) and their receptors: biological functions and role in malignancy.
Iris Appelmann (2010)
10.1158/0008-5472.CAN-07-6705
Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into orthotopic pancreatic tumors in mice.
Sean P Dineen (2008)
10.1002/cncr.10732
Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C‐viral chronic liver diseases
Hiroaki Yamagamim (2002)
10.1002/jcp.22274
Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-κB inhibition via HGF.
P. Bendinelli (2010)
10.1016/0092-8674(88)90567-3
The molecular basis of blood coagulation
B. Furie (1988)
10.1128/MCB.00885-08
Sustained Platelet-Derived Growth Factor Receptor α Signaling in Osteoblasts Results in Craniosynostosis by Overactivating the Phospholipase C-γ Pathway
Anne Moenning (2008)
10.1016/J.BIOMATERIALS.2007.06.037
The potential impact of the preparation rich in growth factors (PRGF) in different medical fields.
E. Anitua (2007)
Transforming growth factors-beta 1 and beta 2 enhance connective tissue formation in animal models of dermal wound healing by secondary intent.
G. A. Ksander (1990)
10.1016/j.ygcen.2009.01.014
The platelet-derived growth factor signaling system in snapping turtle embryos, Chelydra serpentina: potential role in temperature-dependent sex determination and testis development.
T. Rhen (2009)
10.1098/rsif.2010.0118.focus
Titanium oral implants: surface characteristics, interface biology and clinical outcome
A. Palmquist (2010)
10.1177/154405910508400507
Platelet-rich Plasmas: Growth Factor Content and Roles in Wound Healing
J-P Fréchette (2005)
Role of platelet activation and fibrin formation in thrombogenesis
J. Vermylen (1986)
10.1074/jbc.271.30.17629
The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities
M. Clauss (1996)
10.1212/WNL.43.6.1274-b
Regeneration
R. Albin (1993)
10.1016/j.biomaterials.2010.08.006
An in vitro assessment of titanium functionalized with polysaccharides conjugated with vascular endothelial growth factor for enhanced osseointegration and inhibition of bacterial adhesion.
Xuefeng Hu (2010)
10.1016/J.BONE.2003.12.010
Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration.
G. Weibrich (2004)
10.4012/DMJ.26.170
Development of new drug delivery system for implant bone augmentation using a basic fibroblast growth factor-gelatin hydrogel complex.
K. Hayashi (2007)
10.1002/dvdy.20197
PDGFR‐α signaling is critical for tooth cusp and palate morphogenesis
X. Xu (2005)
10.1016/S1079-2104(98)90029-4
Platelet-rich plasma: Growth factor enhancement for bone grafts.
R. Marx (1998)
Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair.
G. Pierce (1992)
10.1038/NBT0298-153
Improving protein therapeutics with sustained-release formulations
S. D. Putney (1998)
10.1684/ecn.2009.0170
VEGF-A: a critical regulator of blood vessel growth.
N. Ferrara (2009)
10.1016/S0735-1097(86)80002-X
Role of platelet activation and fibrin formation in thrombogenesis.
J. Vermylen (1986)
10.1177/03946320110241S203
Scaffolds Combined with Stem Cells and Growth Factors in Healing of Pseudotumoral Lesions of Bone
P. De Biase (2011)
10.1152/AJPENDO.00508.2004
Acute hypoxia decreases plasma VEGF concentration in healthy humans.
K. Oltmanns (2006)
10.1016/J.TIBTECH.2006.02.010
New insights into and novel applications for platelet-rich fibrin therapies.
E. Anitua (2006)
10.1007/s00795-007-0357-8
Vascular endothelial growth factor expression in rat skin incision wound
M. Nogami (2007)
10.1371/journal.pone.0011324
Platelet-Derived Growth Factor Receptor β Is Critical for Zebrafish Intersegmental Vessel Formation
Katie Wiens (2010)
Platelets. London: Academic Press;2007
A. Michelson (2007)
10.1016/S1286-4579(99)00254-3
The role of TGF-β in growth, differentiation, and maturation of B lymphocytes
D. Lebman (1999)
10.1016/J.TIPS.2007.10.010
Delivering growth factors for therapeutics.
E. Anitua (2008)
10.1017/S1462399403005817
Skin repair and scar formation: the central role of TGF-beta.
S. Beanes (2003)
Comparison of methods for point of care preparation of autologous platelet gel.
S. Kevy (2004)
10.1007/s00210-010-0501-1
Lycopene binding compromised PDGF-AA/-AB signaling and migration in smooth muscle cells and fibroblasts: prediction of the possible lycopene binding site within PDGF
C. Chen (2010)
10.1111/j.1600-0501.2011.02164.x
Enhanced bone regeneration around dental implant with bone morphogenetic protein 2 gene and vascular endothelial growth factor protein delivery.
T. Luo (2012)
10.1016/0006-291X(84)91253-1
Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats.
T. Nakamura (1984)
10.1016/J.MPAIC.2010.02.015
Haemostasis, blood platelets and coagulation
Louise Jobling (2010)
The role of TGF-beta in growth, differentiation, and maturation of B lymphocytes.
D. Lebman (1999)
10.1002/JBM.A.30585
Autologous fibrin matrices: a potential source of biological mediators that modulate tendon cell activities.
E. Anitua (2006)
10.1007/s00586-004-0715-3
A new simplified technique for producing platelet-rich plasma: a short technical note
S. Marlovits (2004)
10.1111/j.1749-6632.1990.tb16106.x
Transforming Growth Factors‐β1 and β2 Enhance Connective Tissue Formation in Animal Models of Dermal Wound Healing by Secondary Intent
G. A. Ksander (1990)
10.1016/0014-5793(91)81291-F
Hepatocyte growth factor has potent anti‐proliferative activity in various tumor cell lines
H. Tajima (1991)
10.3109/03008208909002419
The potential role of platelet-derived growth factor as an autocrine or paracrine factor for human bone cells.
D. Graves (1989)
10.1016/J.PROSDENT.2005.08.021
Factors affecting soft tissue around dental implants: a review of the literature.
H. L. Myshin (2005)
10.1016/j.lfs.2010.05.003
Application of a PDGF-containing novel gel for cutaneous wound healing.
R. Judith (2010)
Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants.
E. Anitua (1999)
10.1183/09031936.00174908
Growth factors and interleukin-6 across the lung circulation in pulmonary hypertension
N. Selimovic (2009)
10.1034/j.1600-0544.2002.02205.x
Distribution of fibroblast growth factors (FGFR-1 and -3) and platelet-derived growth factor receptors (PDGFR) in the rat mandibular condyle during growth.
V. Visnapuu (2002)
10.1016/j.transproceed.2009.12.070
Transplantation of microencapsulated cells expressing VEGF improves angiogenesis in implanted xenogeneic acellular dermis on wound.
Y. Han (2010)
10.1016/S0278-2391(97)90187-7
Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery.
Dean H Whitman (1997)
10.1002/jbm.a.33053
Plasma rich in growth factors: the pioneering autologous technology for tissue regeneration.
Eduardo Anitua (2011)
10.1002/btpr.246
Bone tissue engineering: A review in bone biomimetics and drug delivery strategies
Joshua R Porter (2009)
10.1016/S0006-3495(92)81594-1
Computer modeling of fibrin polymerization kinetics correlated with electron microscope and turbidity observations: clot structure and assembly are kinetically controlled.
J. W. Weisel (1992)
Serum levels of IGF-I, HGF, TGFbeta1, bFGF and VEGF in thyroid gland tumors.
D. Vesely (2004)
10.1016/J.EJPB.2004.03.004
Localized delivery of growth factors for bone repair.
V. Luginbuehl (2004)
10.2353/ajpath.2010.090283
Dermal transforming growth factor-beta responsiveness mediates wound contraction and epithelial closure.
M. Martínez-Ferrer (2010)
10.1182/BLOOD.V90.4.1365.1365_1365_1372
Tat-human immunodeficiency virus-1 induces human monocyte chemotaxis by activation of vascular endothelial growth factor receptor-1.
S. Mitola (1997)
10.1016/j.addr.2010.01.001
Potential of endogenous regenerative technology for in situ regenerative medicine.
E. Anitua (2010)
PDGFR-alpha signaling is critical for tooth cusp and palate morphogenesis.
X. Xu (2005)
10.2106/00004623-200206000-00022
The role of growth factors in the repair of bone. Biology and clinical applications.
J. Lieberman (2002)
10.1002/ptr.3150
Wound healing effects of noni (Morinda citrifolia L.) leaves: a mechanism involving its PDGF/A2A receptor ligand binding and promotion of wound closure.
Afa Kehaati Palu (2010)
Hepatocyte growth factor (HGF) acts as a mesenchyme-derived morphogenic factor during fetal lung development.
H. Ohmichi (1998)
10.1097/SAP.0b013e31819f3a3d
PDGF and bFGF Modulate Tube Formation in Adipose Tissue-Derived Stem Cells
S. Keerl (2010)
10.1054/JCMS.2002.0285
Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count.
G. Weibrich (2002)
10.1002/jbm.a.32217
The effects of PRGF on bone regeneration and on titanium implant osseointegration in goats: a histologic and histomorphometric study.
Eduardo Anitua (2009)
10.1006/JSRE.2001.6231
Bimodal concentration-dependent effect of thrombin on endothelial cell proliferation and growth factor release in culture.
V. Borrelli (2001)
10.1016/J.MPAIC.2007.02.008
Haemostasis, blood platelets and coagulation
D. Minors (2004)
10.1146/ANNUREV.IMMUNOL.16.1.137
REGULATION OF IMMUNE RESPONSES BY TGF-β*
J. Letterio (1998)
10.1016/S0006-3495(99)77113-4
Structural origins of fibrin clot rheology.
E. A. Ryan (1999)
10.1371/journal.pone.0011435
VEGF Stimulates RCAN1.4 Expression in Endothelial Cells via a Pathway Requiring Ca2+/Calcineurin and Protein Kinase C-δ
Katherine Holmes (2010)
10.1002/dvdy.21939
An activating mutation in the PDGF receptor alpha results in embryonic lethality caused by malformation of the vascular system
Patricia Kurth (2009)
10.1097/01.prs.0000225430.42531.c2
The Basic Science of Wound Healing
G. Broughton (2006)
10.2165/00007256-200939050-00002
Platelet-Rich Therapies in the Treatment of Orthopaedic Sport Injuries
M. Sánchez (2009)
10.2174/156652406779010795
Immunomodulatory role of vascular endothelial growth factor and angiopoietin-1 in airway remodeling.
T. Makinde (2006)
10.1160/TH03-07-0440
Autologous platelets as a source of proteins for healing and tissue regeneration.
E. Anitua (2004)
10.1182/blood.V64.2.458.bloodjournal642458
Platelet-derived growth factor in vivo: levels, activity, and rate of clearance
D. Bowen-Pope (1984)
10.1111/j.1600-0501.2010.02133.x
The effect of combined delivery of recombinant human bone morphogenetic protein-2 and recombinant human vascular endothelial growth factor 165 from biomimetic calcium-phosphate-coated implants on osseointegration.
M. Ramazanoglu (2011)
10.1007/s11060-010-0259-9
Sunitinib induces PTEN expression and inhibits PDGFR signaling and migration of medulloblastoma cells
T. Abouantoun (2010)
10.1097/01.prs.0000239606.92676.cf
Platelet-Rich Plasma: A Review of Biology and Applications in Plastic Surgery
B. Eppley (2006)
Hepatscyte growth factor has potent anti-proliferative activity in various tumor cell lines
H. Tajima (1991)



This paper is referenced by
10.1002/jbm.a.35240
Effects of calcium-modified titanium implant surfaces on platelet activation, clot formation, and osseointegration.
E. Anitua (2015)
10.1016/j.dental.2018.10.008
Assessing the osteogenic potential of zirconia and titanium surfaces with an advanced in vitro model.
M. Rottmar (2019)
10.1002/jbm.b.33860
Balancing microbial and mammalian cell functions on calcium ion-modified implant surfaces.
Eduardo Anitua (2018)
10.1016/j.jcyt.2014.06.003
Platelet-rich plasma affects bacterial growth in vitro.
E. Mariani (2014)
10.1016/J.PROGPOLYMSCI.2015.02.004
Advancing biomaterials of human origin for tissue engineering.
F. Chen (2016)
10.25063/21457735.262
Humectabilidad, estabilidad instantánea y capacidad procoagulante de diferentes superficies de implantes dentales
Eduardo Anitua (2018)
10.1016/J.RBR.2015.01.007
Plasma rico em plaquetas no tratamento da osteoartrite
Eduardo Knop (2016)
Evaluación in vivo de la osteointegración de implantes con tratamiento de plasma rico en factores de crecimiento (PRGF-Endoret)
Víctor Javier Primo Capella (2013)
10.1016/j.corsci.2020.108528
Engineering nanostructured cell micropatterns on Ti6Al4V by selective ion-beam inhibition of pitting
Rosales López (2020)
10.4317/medoral.21026
Posıtıve effect of platelet rich fibrin on osseointegration
Elif Öncü (2016)
10.1016/J.PROGPOLYMSCI.2014.01.001
Toward the biomimetic implant surface: Biopolymers on titanium-based implants for bone regeneration
Ricardo Tejero (2014)
10.1016/j.msec.2014.03.065
Biodegradable electrospun nanofibers coated with platelet-rich plasma for cell adhesion and proliferation.
L. Diaz-Gomez (2014)
10.1186/s40634-019-0190-8
Optimization of leukocyte-poor platelet-rich plasma preparation: a validation study of leukocyte-poor platelet-rich plasma obtained using different preparer, storage, and activation methods
N. Kikuchi (2019)
Effect of activated autologous platelet-rich plasma on proliferation and osteogenic differentiation of human adipose-derived stem cells in vitro.
Fang-tian Xu (2015)
10.1016/j.pmr.2014.06.008
Treatment of tendinopathies with platelet-rich plasma.
Kenneth R. Mautner (2014)
10.1021/la303360f
Time-of-flight secondary ion mass spectrometry with principal component analysis of titania-blood plasma interfaces.
Ricardo Tejero (2013)
10.1016/j.rbre.2015.07.002
Platelet-rich plasma for osteoarthritis treatment.
Eduardo Knop (2016)
10.1177/1947603513487553
Application of Platelet-Rich Plasma to Disorders of the Knee Joint
Kathryn B. Metcalf (2013)
10.1007/s10856-017-5862-2
3D-printed porous titanium changed femoral head repair growth patterns: osteogenesis and vascularisation in porous titanium
W. Zhu (2017)
Semantic Scholar Logo Some data provided by SemanticScholar